GeoVax Labs Statistics

Total Valuation

GeoVax Labs has a market cap or net worth of $4.58 million. The enterprise value is $3.71 million.

Market Cap	4.58M
Enterprise Value	3.71M

Important Dates

The next estimated earnings date is Monday, July 27, 2026, after market close.

Earnings Date	Jul 27, 2026
Ex-Dividend Date	n/a

Share Statistics

GeoVax Labs has 3.47 million shares outstanding. The number of shares has increased by 342.03% in one year.

Current Share Class	3.47M
Shares Outstanding	3.47M
Shares Change (YoY)	+342.03%
Shares Change (QoQ)	+15.78%
Owned by Insiders (%)	0.11%
Owned by Institutions (%)	15.47%
Float	3.20M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	5.38
Forward PS	n/a
PB Ratio	7.53
P/TBV Ratio	9.29
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	4.35
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.06, with a Debt / Equity ratio of 0.80.

Current Ratio	1.06
Quick Ratio	0.55
Debt / Equity	0.80
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -509.28% and return on invested capital (ROIC) is -305.97%.

Return on Equity (ROE)	-509.28%
Return on Assets (ROA)	-194.58%
Return on Invested Capital (ROIC)	-305.97%
Return on Capital Employed (ROCE)	-3,112.98%
Weighted Average Cost of Capital (WACC)	22.28%
Revenue Per Employee	$44,857
Profits Per Employee	-$1.12M
Employee Count	19
Asset Turnover	0.12
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -94.11% in the last 52 weeks. The beta is 3.63, so GeoVax Labs's price volatility has been higher than the market average.

Beta (5Y)	3.63
52-Week Price Change	-94.11%
50-Day Moving Average	1.58
200-Day Moving Average	5.94
Relative Strength Index (RSI)	43.74
Average Volume (20 Days)	908,680

Short Selling Information

The latest short interest is 584,471, so 16.83% of the outstanding shares have been sold short.

Short Interest	584,471
Short Previous Month	470,940
Short % of Shares Out	16.83%
Short % of Float	18.26%
Short Ratio (days to cover)	0.04

Income Statement

In the last 12 months, GeoVax Labs had revenue of $852,282 and -$21.37 million in losses. Loss per share was -$15.94.

Revenue	852,282
Gross Profit	-15.82M
Operating Income	-21.51M
Pretax Income	-21.37M
Net Income	-21.37M
EBITDA	-21.44M
EBIT	-21.51M
Loss Per Share	-$15.94

Full Income Statement

Balance Sheet

The company has $1.27 million in cash and $394,571 in debt, giving a net cash position of $877,191 or $0.25 per share.

Cash & Cash Equivalents	1.27M
Total Debt	394,571
Net Cash	877,191
Net Cash Per Share	$0.25
Equity (Book Value)	493,770
Book Value Per Share	0.18
Working Capital	139,783

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$19.05 million and capital expenditures -$10,718, giving a free cash flow of -$19.06 million.

Operating Cash Flow	-19.05M
Capital Expenditures	-10,718
Depreciation & Amortization	63,911
Net Borrowing	n/a
Free Cash Flow	-19.06M
FCF Per Share	-$5.49

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-2,523.43%
Pretax Margin	-2,507.27%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

GeoVax Labs does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-342.03%
Shareholder Yield	-342.03%
Earnings Yield	-466.09%
FCF Yield	-415.66%

Analyst Forecast

The average price target for GeoVax Labs is $10.00, which is 657.58% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$10.00
Price Target Difference	657.58%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (3Y)	n/a
EPS Growth Forecast (3Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on January 12, 2026. It was a reverse split with a ratio of 1:25.

Last Split Date	Jan 12, 2026
Split Type	Reverse
Split Ratio	1:25

Scores

GeoVax Labs has an Altman Z-Score of -93.67 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-93.67
Piotroski F-Score	1